Skip to main content
Premium Trial:

Request an Annual Quote

People in the News

Oxford Nanopore Technologies: Justin O'Grady

Justin O'Grady has joined Oxford Nanopore Technologies as senior director of translational applications. Previously, he was a senior lecturer in medical microbiology at the University of East Anglia, and before that, a group leader at the Quadram Institute. He holds PhD, MSc, and BSc degrees in microbiology from the National University of Ireland, Galway.

908 Devices: Marcia Eisenberg

Mini mass spectrometry device maker 908 Devices has appointed Marcia Eisenberg, CSO of Labcorp Diagnostics, to its board of directors. She previously held roles on the National Institute of Environmental Health Sciences and the FBI’s National DNA Advisory Board and has extensive experience with forensic DNA testing, biotechnology, molecular genetics, and molecular oncology, according to Boston-based 908 Devices.

Pacific Biosciences: Neil Ward

Pacific Biosciences has appointed Neil Ward as VP and general manager for Europe, the Middle East, and Africa.

Ward comes to PacBio from Illumina, where he was senior sales director for Northern Europe. Prior to his 13 years at Illumina, he held bioinformatics and sales roles at Agilent Technologies, Silicon Genetics, Oxford Biomedica, and Celltech. Ward holds a master's degree in bioinformatics from the University of Manchester.

Bionano Genomics: Jason Priar

Bionano Genomics has appointed Jason Priar as chief commercial officer. He will lead the commercial teams in the firm's platforms and services businesses.

Priar comes to Bionano from PerkinElmer Genomics, where he was VP of commercial in the firm's global labs business. Previously, he led sales at Sema4 and GeneDx.

KCAS Bioanalytical and Biomarker Services: John Pirro

KCAS Bioanalytical and Biomarker Services has named John Pirro as senior director of biopharmaceutical services. He joins the company from WuXi AppTec, where he was head of large- and small-molecule customer bioassays and clinical diagnostic development programs. He holds a BS in cell biology from the University of Iowa.

Verily: Amy Abernethy

Verily has appointed Amy Abernethy as president of its clinical research business. Abernethy was most recently principal deputy commissioner of food and drugs and acting chief information officer at the US Food and Drug Administration. Prior to her role at FDA, Abernethy was chief medical officer, chief scientific officer, and senior vice president of Flatiron Health, now part of Roche. Abernethy has also been a professor of medicine at Duke University School of Medicine; director of the Center for Learning Health Care in the Duke Clinical Research Institute; and director of the Duke Cancer Care Research Program in the Duke Cancer Institute.

23andMe: Wade Walke

Wade Walke has joined 23andMe as VP of investor relations. Previously, he held the same title at Ionis Pharmaceuticals, and before that, he held various positions at Lexicon Pharmaceuticals, including associate director of bioinformatics in the department of functional genomics and head of communications and investor relations. Walke holds a BSc from Brigham Young University as well as PhD and MSc degrees from the University of Michigan.

Lucence: Gilberto de Lima Lopes

Lucence has appointed Gilberto de Lima Lopes to its newly formed medical advisory board. Lopes currently serves as interim chief for the division of medical oncology Sylvester Comprehensive Cancer Center at the University of Miami. Lopes also serves as editor in chief of the American Society of Clinical Oncology's Journal of Global Oncology. 

Resolve Biosciences: Chris Barbazette

Resolve Biosciences has appointed Chris Barbazette as chief commercial officer. He will lead the firm's growing sales and marketing operations. Prior to this, he was senior VP of global sales and support at GenapSys. He has also held executive positions at Agendia and Affymetrix.

Genomtec: Charudutt Shah

Genomtec announced that Charudutt Shah is joining the board starting August 1. Shah is currently the marketing director at BioMérieux where he is responsible for commercial marketing in Europe, Middle East, and Africa. He oversees the launch of BioFire's syndromic infectious disease panels and instruments and develops go to market strategies for the firm's products. He previously worked at Spartan Bioscience as business development director responsible for sales, marketing, and product distribution strategies internationally. Shah was also a global marketing manager at Luminex managing the firm's PCR respiratory viral panel.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.